| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
October 25, 2022 |
|
|
| |
|
|
| |
|
|
|
Xtalks, online
2022 -11-02
Successful gene therapy using AAV vectors requires high titers of functional virus. A challenge in AAV production is the requirement for highly customized buffer formulations for each drug construct. In particular, thorough consideration of the buffers utilized is required in order to achieve full capsid enrichment in the final anion-exchange chromatography polishing step due to the unique capsid and transgene combination. In this webinar, the speaker will discuss the discreet, critical parameters that effect the downstream workflow for optimized AAV production.
Register for this webinar to learn about key buffer considerations for AAV full capsid enrichment.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Bella Neufeld, PhD, Director of Research and Development, Teknova
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2022 -11-02
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|